Yucai Wang, MD, PhD¹, Nicolaus Wagner-Bartak, MD^2*, Shouhao Zhou, PhD^3*, Nathan Fowler, MD⁴, Maria Lourdes Dela Rosa^5*, Donglu Zhao, MD^5*, Jorge E. Romaguera, MD⁴, Sattva S. Neelapu, MD⁵, Fredrick B. Hagemeister, MD⁴, Michelle A. Fanale, MD⁴, Yasuhiro Oki, MD⁵, Jatin J. Shah, MD⁵, Sheeba K. Thomoas, MD^5*, Chitra M. Hosing, MD⁶, Liang Zhang, MD, PhD⁵, Maria Badillo^5*, Wendy Chen^5*, Qingqing Cai, MD, PhD^5*, Dehui Zou, MD, PhD^5*, Richard E. Champlin, MD⁶, Luis E. Fayad, MD⁵, Hun Ju Lee, MD^5* and Michael Wang, MD⁵

¹Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ
²Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁶Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX

Roch Houot, MD, PhD^1*, Carole Soussain, MD², Hervé Tilly, MD, PhD³, Corinne Haioun, MD, PhD⁴, Catherine Thieblemont⁵, Olivier Casasnovas, MD^6*, Krimo Bouabdallah, MD^7*, Franck Morschhauser, MD^8*, Steven Le Gouill, MD, PhD^9*, Gilles A. Salles, MD, PhD¹⁰, Tony Marchand, MD^11*, Céline Pangault, PharmD PhD^1*, Camille Laurent^12* and Thierry Lamy, MD, PhD¹³

¹INSERM U917 - CHU de Rennes, Rennes, France
²Dept. of Hematologie, Centre Rene Huguenin, Saint-Cloud, France
³INSERM U918, Centre Henri Becquerel, Rouen, France
⁴Lymphoid Malignancies Unit, CHU Henri Mondor, Créteil, France
⁵Hôpital Saint-Louis, Paris, France
⁶Hematology Department, Hopital Le Bocage, CHU Dijon, Dijon, France
⁷CHU de Bordeaux, Bordeaux, France
⁸Hematologie, Centre Hospitalier Universitaire, Université de Lille 2, Lille, France
⁹Department of Hematology, Nantes University Hospital, Nantes, France
¹⁰Department of Hematology, Centre Hospitalier Lyon-Sud, Pierre-Benite, France
¹¹Department of Hematology, Centre Hospitalier Universitaire de Rennes, Rennes, France
¹²Institut Universitaire du Cancer-Oncopole de Toulouse, Toulouse, France
¹³Haematology, CHU Pontchaillou, Rennes, France

Elizabeth Punnoose^1*, Franklin V. Peale Jr.^1*, Guiyuan Lei^2*, Thomas Sandmann^1*, Richard Bourgon^1*, Edith Szafer-Glusman^1*, An Do^1*, Randy D. Gascoyne^3,4, Gilles A. Salles, MD, PhD⁵, John F. Seymour, MBBS, PhD^6,7, Marek Trneny⁸, Laurie H. Sehn^4,9, F. Javier Munoz^10* and Kirsten E. Mundt, PhD^10*

¹Genentech, Inc., South San Francisco, CA
²Roche Products Ltd, Welwyn Garden City, United Kingdom
³British Columbia Cancer Agency, Centre for Lymphoid Cancer, Department of Pathology and Laboratory Medicine, Vancouver, BC, Canada
⁴Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada
⁵Hospices Civils de Lyon, University Claude Bernard, Pierre-Benite, France
⁶Peter MacCallum Cancer Centre, Melbourne, Australia
⁷University of Melbourne, Melbourne, Australia
⁸Department of Hematology, General Hospital, Charles University, Prague, Czech Republic
⁹University of British Columbia, Vancouver, Canada
¹⁰F. Hoffmann-La Roche Ltd, Basel, Switzerland

Mathias Rummel, MD, PhD^1*, Tae Min Kim, MD, PhD², Caterina Plenteda, MD^3*, Enrico Capochiani, MD^4*, Maria Mendoza^5*, Rodney Smith, MD, PhD^5*, Stuart Osborne, MSc^5* and Andrew Grigg, MBBS, MD, FRACP, FRACPA^6*

¹University Hospital Giessen and Marburg, Giessen, Germany
²Seoul National University Hospital, Seoul, South Korea
³Universita Degli Studi Parma, Parma, Italy
⁴Centro Aziendale di Ematologia, Livorno, Italy
⁵F. Hoffmann-La Roche Ltd, Basel, Switzerland
⁶Austin Health, Heidelberg, Australia

Barbara Kiesewetter, MD^1*, Richard Greil, MD², Wolfgang Willenbacher, MD^3*, Peter Neumeister, MD^4*, Michael A. Fridrik, MD^5* and Raderer Markus, MD^6*

¹Dept. of Medicine I, Clin. Div. of Oncology, Medical University of Vienna, Vienna, Austria
²Dept. of Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectiology and Rheumatology, University Hospital Salzburg, Salzburg, Austria
³Dept. of Medicine V, Hematology & Oncology, Innsbruck Medical University, Innsbruck, Austria
⁴Internal Medicine / Hematology, Medical Universitiy of Graz, Graz, Austria
⁵Dept. of Medicine III, AKH Linz, Linz, Austria
⁶Dept. Medicine I, Clin. Div. of Oncology, Medical University of Vienna, Vienna, Austria

Vera Dufner^1*, Maria-Elisabeth Goebeler^2*, Cyrus Sayheli^2* and Ralf C. Bargou³

¹Comprehensive Cancer Center Mainfranken, Würzburg, Germany
²University Hospital Würzburg, Würzburg, Germany
³Würzburg University Medical Center, Comprehensive Cancer Center Mainfranken, Würzburg, Germany

Pallawi Torka, MD¹, Priyank P. Patel, MD^1*, Wei Tan^2*, Gregory Wilding^2*, Seema A. Bhat, MD¹, Myron S. Czuczman, MD³, Kelvin P. Lee, MD³, George Deeb, MD⁴, Vishala T. Neppalli, MD⁴, Cory Mavis, MSc^3* and Francisco J. Hernandez-Ilizaliturri, MD³

¹Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY
²Department of Biostatistics, Roswell Park Cancer Institute, Buffalo, NY
³Departments of Medicine and Immunology, Roswell Park Cancer Institute, Buffalo, NY
⁴Department of Pathology, Roswell Park Cancer Institute, Buffalo, NY

Ahmed Sawas, MD¹, Kerry J. Savage, MD MSc^2,3, Raymond Perez, MD^4*, Ranjana H Advani, MD^5,6, Anna Butturini, MD⁷, Jacqueline Lackey^7*, Fabio Trave, MD^7*, Banmeet Anand, PhD^8*, Yao Huang^9*, Leonard Reyno, MD^9* and Owen A. O'Connor, MD^1,10

¹Center for Lymphoid Malignancies, Columbia University Medical Center, New York, NY
²British Columbia Cancer Agency, Centre for Lymphoid Cancer and Department of Medical Oncology, Vancouver, BC, Canada
³Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada
⁴University of Kansas Clinical Research Center, Fairway, KS
⁵Stanford University Medical Center, Stanford, CA
⁶Oncology, Department of Internal Medicine, Stanford University Medical Center, Stanford, CA
⁷An affiliate of Astellas Pharma, Inc., Agensys Inc., Santa Monica, CA
⁸Agensys Inc., an Affiliate of Astellas Pharma Inc., Santa Monica, CA
⁹An affiliate of Astellas Pharma, Inc., Agensys, Inc., Santa Monica, CA
¹⁰Columbia University Medical Center, New York, NY

Barbara Marie Galligan, MD¹, Denice Tsao-Wei^2*, Susan Groshen^2*, Mark Kirschabum^3*, Robert O'Donnell^1*, Paul R. Kaesberg, MD¹, Tanya Siddiqui^4*, Leslie Popplewell^4*, Ailawadhi Sikander^5*, Htut Myo^4*, Robert Chen⁴, John F. DiPersio, MD, PhD⁶, Neil D. Palmisiano, MD⁷, David F. Claxton, M.D.^8*, Edward M. Newman, PhD^4* and Joseph Tuscano, MD¹

¹University of California Davis, Sacramento, CA
²University of Southern California, Los Angeles
³North Shore - LIJ, Forest Hills
⁴City of Hope, Duarte, CA
⁵Mayo Clinic, Minneapolis
⁶Department of Medicine, Division of Oncology, Washington University School of Medicine, Saint Louis, MO
⁷Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA
⁸Hematology/Oncology Division, Penn State Hershey Cancer Institute, Penn State University, Hershey, PA

Christiane Pott, MD, PhD^1*, David Belada, MD, PhD^2*, Nathalie Danesi, PhD^3*, Günter Fingerle-Rowson, MD, PhD³, John Gribben, MD, DSc⁴, Chris Harbron, MPhil^3*, Eva Hoster, PhD^5*, Brad S Kahl, MD⁶, Kirsten Mundt, PhD^7*, Catherine Sebban, MD^8*, Laurie H Sehn, MD, MPH⁹ and Bruce D. Cheson, MD¹⁰

¹University Hospital Schleswig-Holstein, Kiel, Germany
²IV. Hematological dpt., IV Interni Hematologicka Klinika, Hradec Kralove, Czech Republic
³F. Hoffmann-La Roche Ltd, Basel, Switzerland
⁴Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom
⁵University Hospital Grosshadern, Munich, Germany
⁶Washington University, St.Louis, MO
⁷Genentech, Inc., South San Francisco, CA
⁸Hematology, University of Lyon, Lyon, France
⁹British Columbia Cancer Agency and the University of British Columbia, Vancouver, BC, Canada
¹⁰Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC

Charles Herbaux, MD^1*, Jordan Gauthier, MD^2*, Pauline Brice, MD³, Luc Fornecker, MD^4*, Krimo Bouabdallah, MD^5*, Guillaume Manson^6*, Hervé Ghesquières, MD^7*, Anne Thiebaut-Bertrand, MD^8*, Hélène Demarquette^1*, Eileen Boyle^1*, Loic Ysebaert, MD, PhD^9*, Roch Houot, MD, PhD^10*, Ibrahim Yakoub-Agha, MD, PhD¹¹ and Franck Morschhauser, MD^12*

¹Maladies du Sang, Hôpital Claude Huriez, CHRU Lille, Lille, France
²CHRU Lille Hopital Huriez, Lille, France
³Hematology, AP-HP Hopital Saint-Louis, Paris, France
⁴Oncology and Hematology, Hopital de Hautepierre, Strasbourg, France
⁵CHU de Bordeaux, Bordeaux, France
⁶CHU de Rennes, Rennes, France
⁷Department of Haematology, centre Leon Berard, lyon, France
⁸CHU de Grenoble, Grenoble, France
⁹CHU Purpan, Toulouse, France
¹⁰INSERM U917 - CHU de Rennes, Rennes, France
¹¹Hematology, CHU de Lille, Lille, France
¹²Hematologie, Centre Hospitalier Universitaire, Université de Lille 2, Lille, France

Kathryn Kolibaba, MD^1,2, John M. Burke, MD^2,3, Heather D. Brooks, MD, BS, BA^2,4*, Daruka Mahadevan, MD, PhD⁵, Jason Melear, MD^2,6, Charles M. Farber, MD, PhD⁷, Suzanne R. Fanning, DO^2,8, Marshall T. Schreeder, MD⁹, Ralph V. Boccia, MD¹⁰, Peter Sportelli¹¹, Hari P. Miskin, MS^11*, Michael S. Weiss^11* and Jeff P. Sharman, MD^2,12

¹Medical Oncology / Hematology, Compass Oncology, Vancouver, WA
²US Oncology Research, The Woodlands, TX
³Rocky Mountain Cancer Centers/US Oncology Research, Aurora, CO
⁴Blue Ridge Cancer Care, Blacksburg, VA
⁵West Cancer Center/UTHSC, Memphis, TN
⁶Texas Oncology, Austin, TX
⁷Carol G. Simon Cancer Center, Morristown Medical Center, Morristown, NJ
⁸Greenville Heath System Cancer Institute, Greenville, SC
⁹Clearview Cancer Institute, Huntsville, AL
¹⁰The Center for Cancer and Blood Disorders, Bethesda, MD
¹¹TG Therapeutics, Inc., New York, NY
¹²Willamette Valley Cancer Institute, Springfield, OR

Zuolin Ying, MD, PhD^*, Madeleine Duvic, MD, Lisa Shiue, PhD^*, Timothy Langridge, BS^*, Meghali Goswami, BS^* and Xiao Ni, MD, PhD

Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX

Ann S. LaCasce, MD¹, Gregory Bociek², Ahmed Sawas³, Paolo F. Caimi, MD⁴, Edward Agura⁵, Jeffrey Matous⁶, Stephen Ansell, MD, PhD⁷, Howland Crosswell, MD⁸, Miguel Islas-Ohlmayer^9*, Caroline Behler¹⁰, Eric Cheung^11*, Andres Forero-Torres¹², Julie Vose², Owen A. O'Connor, MD³, Neil Josephson¹³ and Ranjana Advani¹⁴

¹Dana-Farber Cancer Institute, Boston, MA
²University of Nebraska Medical Center, Omaha, NE
³Columbia University Medical Center, New York, NY
⁴University Hospitals Case Medical Center, Cleveland, OH
⁵Charles A. Sammons Cancer Center, Dallas, TX
⁶Colorado Blood Cancer Institute, Denver, CO
⁷Mayo Clinic, Rochester, MN
⁸Bon Secours St. Francis Hospital, Greenville, SC
⁹The Jewish Hospital-Mercy Health, Cincinnati, OH
¹⁰Pacific Hematology Oncology Associates, San Francisco, CA
¹¹The Oncology Institute of Hope and Innovation, Whittier, CA
¹²University of Alabama at Birmingham, Birmingham, AL
¹³Seattle Genetics, Inc., Bothell, WA
¹⁴Stanford Cancer Center, Stanford, CA

Beth A Christian, MD¹, John G. Kuruvilla, MD², Sonali M. Smith, MD³, Pierluigi Porcu, MD⁴, Kami J. Maddocks, MD⁵, Amy S. Ruppert, MAS^6*, John C Byrd, M.D.¹, Michael R. Grever, MD⁷ and Kristie A. Blum, MD⁸

¹Comprehensive Cancer Center, The Ohio State University, Columbus, OH
²Division of Medical Oncology and Hematology, University of Toronto,Princess Margaret Cancer Centre, Toronto, ON, Canada
³University of Chicago, Chicago, IL
⁴The Ohio State University Wexner Medical Center, Columbus, OH
⁵The Ohio State University, Columbus, OH
⁶Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
⁷Division of Hematology and Oncology, The Ohio State University, Columbus, OH
⁸Division of Hematology, The Ohio State University, Columbus, OH

Dai Chihara, MD, PhD¹, Michelle A. Fanale, MD¹, Mansoor Noorani^1*, Jason R Westin, MD¹, Loretta Nastoupil, MD¹, Fredrick B. Hagemeister, MD¹, Luis E. Fayad, MD¹, Jorge E. Romaguera, MD¹, Felipe Samaniego, M.D.¹, Francesco Turturro, MD¹, Hun Ju Lee, MD^1*, Sattva S. Neelapu, MD¹, Alma Rodriguez, M.D.^1*, Michael Wang, MD¹, Nathan Fowler, MD¹, Roberto N. Miranda, MD², Chitra M. Hosing, MD³, Yago Nieto, MD, PhD³, Richard Eric Davis, M.D.^1* and Yasuhiro Oki, MD¹

¹Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX

Carola Boccomini, MD^1*, Marco Ladetto, MD^2*, Francesca Dutto^2*, Simone Ferrero, MD^2*, Luca Baldini, MD^2*, Chiara Bottelli, MD^2*, Claudia Castellino, MD^2*, Annalisa Chiarenza, MD^2*, Annarita Conconi, MD^2*, Federico De Angelis, MD^2*, Andrea Evangelista^2*, Stefan Hohaus, MD^2*, Francesco Merli, MD^2*, Benedetta Puccini, MD^2*, Chiara Rusconi, MD^2*, Eleonora Russo, MD^2*, Stefano Sacchi, MD^2*, Stefano Volpetti, MD^2*, Giuseppe Rossi, MD^2* and Umberto Vitolo, MD²

¹SC Hematology, Città della Salute e della Scienza di Torino, Turin, Italy
²on the behalf of Fondazione Italiana Linfomi (FIL), Turin, Italy

Pier Luigi Zinzani, MD, PhD¹, Vincent Ribrag, MD^2*, Craig H. Moskowitz, MD^3*, Jean-Marie Michot^4*, John Kuruvilla, MD⁵, Arun Balakumaran, MD, PhD, SM^6*, Ellen Snyder, PhD^6*, Patricia Marinello, PharmD^6*, Margaret A. Shipp, MD⁷ and Philippe Armand, MD, PhD⁷

¹Institute of Hematology “L. & A. Seràgnoli”, University of Bologna, Bologna, Italy
²DITEP/medicine, Gustave Roussy Cancer Campus, Villejuif, France
³Memorial Sloan Kettering Cancer Center, New York, NY
⁴Gustave Roussy Comprehensive Cancer Center, Villejuif, France
⁵Division of Medical Oncology and Hematology, University of Toronto, Princess Margaret Cancer Centre, Toronto, ON, Canada
⁶Merck & Co., Inc., Kenilworth, NJ
⁷Dana-Farber Cancer Institute, Boston, MA

Dai Chihara, MD, PhD¹, Yasuhiro Oki, MD¹, Jason R Westin, MD¹, Loretta Nastoupil, MD¹, Luis E. Fayad, MD¹, Felipe Samaniego, MD¹, Emily Wesson, APN^1*, Charnelle Ruben, BS^1*, Sandra B. Horowitz, PharmD^2*, Lei Feng, MS^3*, Naveen Garg^4*, Sairah Ahmed, MD⁵, Issa F. Khouri⁵, Chitra M. Hosing, MD⁵, Jorge E. Romaguera, MD¹, Nathan Fowler, MD¹ and Michelle A. Fanale, MD¹

¹Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX

Jeffrey P. Ward, MD, PhD¹, Jessica Thein^2*, Jingqin Luo, Ph.D^2*, Nina D. Wagner-Johnston, MD³, Amanda F. Cashen, MD⁴, Todd A Fehniger, MD, PhD¹ and Nancy L Bartlett, MD⁴

¹Division of Oncology, Department of Medicine, Washington University School of Medicine, Saint Louis, MO
²Washington University School of Medicine, St. Louis, MO
³Department of Medicine, Washington University School of Medicine, St Louis, MO
⁴Washington University School of Medicine, Saint Louis, MO

Corrado Tarella, MD^1,2*, Angela Gueli^3*, Federica Delaini^4*, Anna Maria Barbui, MD^5*, Riccardo Bruna^6*, Daniele Caracciolo^7*, Daniela Gottardi^8*, Giuseppe Gritti, MD^5*, Roberto Passera, PharmD, PhD^9*, Safaa Ramadan, PhD, MD^3,10*, Andrea Rossi, MD^11* and Alessandro Rambaldi, MD⁵

¹University of Torino, TORINO, Italy
²European Institute of Oncology, Division of Hematoncology, Milan, Italy
³European Institute of Oncology, Milano, Italy
⁴Department of Hematology, Hospital Papa Giovanni XXIII, BERGAMO, Italy
⁵Department of Hematology, Hospital Papa Giovanni XXIII, Bergamo, Italy
⁶Hematology and Cell Therapy Division, Mauriziano Hospital, TORINO, Italy
⁷Division of Hematology I, A. O. Città della Salute, TORINO, Italy
⁸Hematology and Cell Therapy Division, Mauriziano Hospital, Torino, Italy, TORINO, Italy
⁹Division of Nuclear Medicine, AOU Città della Salute e della Scienza, Turin, Italy
¹⁰National Cancer Institute-Cairo University, Cairo, Egypt
¹¹Hematology and Bone Marrow Transplant Unit, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy

Natalie Galanina, MD¹, Sonali M. Smith, MD¹, Chuanhong Liao, PhD^2*, Adam M. Petrich, MD³, Bernadette Libao^2*, Ron Gartenhaus, MD⁴, Jason R Westin, MD⁵, Kenneth S. Cohen, MD¹, James Knost, MD^6*, Walter Stadler, MD¹, Austin Doyle, MD^7*, Theodore Karrison, PhD^2*, Leo I. Gordon, MD³ and Andrew M Evens, DO, MS⁸

¹Division of Hematology/Oncology, University of Chicago, Chicago, IL
²University of Chicago, Chicago, IL
³Northwestern University Feinberg School of Medicine, Division of Hematology/Oncology, Chicago, IL
⁴Greenebaum Cancer Center, University of Maryland, Baltimore, MD
⁵Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁶Illinois Cancer Care, Preoria, IL
⁷National Cancer Institute, Bethesda, MD
⁸University of Massachusetts Medical School University Hospital, Worcester, MA

Frederick L. Locke, MD¹, Sattva S. Neelapu, MD², Nancy L Bartlett, MD³, Tanya Siddiqi, MD⁴, Julio C. Chavez, MD⁵, Chitra M. Hosing, MD⁶, Armin Ghobadi, MD⁷, Lihua E. Budde, MD, PhD⁸, Lynn Navale, MS^9*, Jeff S. Aycock, BA^9*, Jeff Wiezorek, MD, MS^9* and William Y. Go, MD, PhD⁹

¹Blood and Marrow Transplantation, Moffitt Cancer Center, Tampa, FL
²Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
³Washington University School of Medicine, Saint Louis, MO
⁴Hematology & Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
⁵Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
⁶Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
⁷Siteman Cancer Center, Washington University, St Louis, MO
⁸Department of Hematology & Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
⁹Kite Pharma, Santa Monica, CA

Matthew J Maurer, MS¹, Carrie A. Thompson, MD², Umar Farooq, MD³, Tasha Lin, MD², Grzegorz S. Nowakowski, MD², Yi Lin, MD, PhD², Ivana Micallef, MD², Anne Novak, PhD⁴, William Macon, MD^4*, Sergei Syrbu, MD^5*, James Cerhan, MD, PhD¹, Thomas E. Witzig, MD², Thomas M. Habermann, MD², Stephen Ansell, MD, PhD⁴ and Brian K Link, MD³

¹Department of Health Sciences Research, Mayo Clinic, Rochester, MN
²Division of Hematology, Mayo Clinic, Rochester, MN
³Division of Hematology, Oncology and Blood & Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, IA
⁴Mayo Clinic, Rochester, MN
⁵University of Iowa, Iowa City, IA